PALACOS RG 1X40 SINGLE N/A 00111314001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2020-03-27 for PALACOS RG 1X40 SINGLE N/A 00111314001 manufactured by Zimmer Biomet, Inc..

Event Text Entries

[186169238] Zimmer biomet complaint number (b)(4). Concomitant medical products: articular surface fixed bearing; p/n: 42511200416 , l/n: 62632159, femur cemented; p/n: 42502605801, l/n: 63702261, tibia cemented; p/n: 42532006701, l/n: 63683014, all poly patella cemented; p/n: 42540000032, l/n: 63764251, palacos rg 1x40 single; p/n: 00111314001, l/n: 85714575l16. Reported event was confirmed by review of medical records. Medical records were provided and reviewed by a health care professional. Review of the available records identified no complications during the removal of antibiotic spacers and implantation of persona primary components. No evidence of infection was noted. Review of the records from the revision surgery identified the patient was experiencing increasing pain in the latera tibial plateau and severe pain with ambulation. Osteolysis was noted on the lateral tibial plateau. Extensive scar tissue was excised. The femoral component was noted to be loose and it was identified that cement had adhered to the femoral and tibial components but not to the bone. No wear was noted on the articular surface and no signs of infection were present. The patella was not revised. Dhr was reviewed and no discrepancies were found. Per the persona knee system package insert, pain, loosening, and osteolysis are known potential adverse effects of this procedure. Root cause was unable to be determined. A summary of the investigation has been sent to the complainant. If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly. Zimmer biomet will continue to monitor for trends. Multiple mdr reports were filed for this event, please see associated reports: 3007963827 - 2020 - 00008 - 1. 3007963827 - 2019 - 00281 - 2. 0001822565 - 2020 - 01126.
Patient Sequence No: 1, Text Type: N, H10


[186169239] It was reported the patient had a revision procedure 2 years post-implantation due to osteolysis, pain and loosening. Subsequently, all components were revised expect the patella. The surgeon noted during the revision procedure that the bone cement had adhered to the femoral and tibial implants, but not the patient's bone. Further, the surgeon noted the patient had extensive scar tissue that was excised. No additional patient consequences were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number0001822565-2020-01126
MDR Report Key9889452
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2020-03-27
Date of Report2020-03-27
Date of Event2019-12-11
Date Mfgr Received2020-03-24
Device Manufacturer Date2016-12-09
Date Added to Maude2020-03-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. CHRISTINA ARNT
Manufacturer Street56 E. BELL DR.
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal46582
Manufacturer Phone5745273773
Manufacturer G1ZIMMER BIOMET, INC.
Manufacturer Street56 E. BELL DRIVE
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal Code46582
Single Use3
Previous Use Code3
Removal Correction NumberN/A
Event Type3
Type of Report3

Device Details

Brand NamePALACOS RG 1X40 SINGLE
Generic NameBONE CEMENT
Product CodeLOD
Date Received2020-03-27
Model NumberN/A
Catalog Number00111314001
Lot Number85714575
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerZIMMER BIOMET, INC.
Manufacturer Address56 E. BELL DRIVE WARSAW IN 46582 US 46582


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2020-03-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.